Data as of Nov 26
| +0.09 / +0.20%|
The 16 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 46.50, with a high estimate of 54.00 and a low estimate of 42.00. The median estimate represents a +5.08% increase from the last price of 44.25.
The current consensus among 19 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.